Last reviewed · How we verify
NCT04962256
ERAS in Posterior Approach of Cervical Spine Operation
trial testing Enhanced recovery after surgery in Cervical Myelopathy in 204 participants. Completed in 31 March 2022.
31 March 2022
Quick facts
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 204 |
| Start date | 20 March 2019 |
| Primary completion | 31 March 2022 |
| Estimated completion | 31 March 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- Enhanced recovery after surgery — full drug profile →
Conditions studied
- Cervical Myelopathy — all drugs for Cervical Myelopathy →
Sponsor
Peking University Third Hospital
Who can join
Adults 18 to 70, any sex, with Cervical Myelopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Enhanced recovery after surgery (ERAS) strategy has been used in the patient management of different diseases. This study aims to evaluate the effectiveness of ERAS in the perioperative period of posterior approach of cervical spine operation among patients with CSM.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04962256
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Enhanced recovery after surgery
Trials testing the same drug.
- NCT06577389 — Enhanced Recovery After Surgery for Spine Fusion Surgeries in the Elderly · not yet recruiting
- NCT06241482 — Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care · NA · recruiting
- NCT04955496 — ERAS on Cervical Surgery · completed
- NCT04543214 — Outcome of Enhanced Recovery After Surgery (ERAS) Protocols in Patients Undergoing Small Bowel Surgery · completed
Other recruiting trials for Cervical Myelopathy
Currently open trials in the same condition.
- NCT06893406 — Cervical Myelopathy in Hip Fracture Patients · NA · recruiting
- NCT06701422 — Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery · NA · recruiting
- NCT06520020 — Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal · NA · recruiting
- NCT06486038 — Quatitative MRI of the Spinal Cord in Cervical Myelopathy: Assessment of Microstuctural Damage for Outcome Improvement · NA · recruiting
- NCT05183971 — Proprioceptive Deficits in Degenerative Cervical Myelopathy · recruiting
Other Peking University Third Hospital trials
Trials by the same sponsor.
- NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
- NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
- NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
- NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
- NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04962256 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
- Last refreshed: 12 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04962256.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing